xatral alfuzosin hydrochloride 2.5 mg tablet blister pack
sanofi-aventis australia pty ltd - alfuzosin hydrochloride -
xatral 2.5mg tablets
pco manufacturing - alfuzosin hydrochloride - tablets - 2.5mg milligram
xatral
novartis new zealand ltd - alfuzosin hydrochloride 2.5mg; - film coated tablet - 2.5 mg - active: alfuzosin hydrochloride 2.5mg excipient: hypromellose lactose monohydrate macrogol stearate 400 magnesium stearate microcrystalline cellulose povidone sodium starch glycolate titanium dioxide
xatral sr
novartis new zealand ltd - alfuzosin hydrochloride 5mg; - modified release tablet - 5 mg - active: alfuzosin hydrochloride 5mg excipient: calcium hydrogen phosphate dihydrate hydrogenated castor oil hypromellose iron oxide red magnesium stearate microcrystalline cellulose povidone propylene glycol titanium dioxide
xatral 2.5 mg
sanofi - aventis israel ltd - alfuzosin hydrochloride 2.5 mg - tablets - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, notably when surgery has to be delayed for whaterver reason and during episodes of severe symptoms of adenoma, especially in elderly patients.
xatral lp tablets (pom)
alfuzosine 10mg
xatral lp x 30's
alfuzosin 10mg
xatral 5mg s.r.f.c.tab.
sanofi aventis-france - coated tablet - 5 mg
xatral film coated tablet 2.5 mg
bahrain pharmacy - alfuzosin hydrochloride - film coated tablet - 2.5
xatral xl prolonged-release tablets 10 mg
bahrain pharmacy - alfuzosin hydrochloride - prolonged-release tablets - 10